We then examined cancer genome data (Gene Expression database of Normal and Tumor tissues, GENT2) to assess the relative mRNA levels in normal versus tumorigenic human tissues, which pointed toward higher expression of GLS, the enzyme that converts glutamine to glutamate as the first step of glutaminolysis, and other enzymes involved in glutamine metabolism in many tumor types (fig. This evidence concerns the gene GLS and cancer.